Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population--a Randomized Controlled Pilot Study
Phase of Trial: Phase I/II
Latest Information Update: 29 May 2016
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions
- Acronyms SJHHVTE
- 22 Sep 2015 Planned End Date changed from 1 Sep 2016 to 1 Aug 2017 as reported by ClinicalTrials.gov.
- 22 Sep 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.
- 22 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov